Derek J. Maetzold
Net Worth
Last updated:
What is Derek J. Maetzold net worth?
The estimated net worth of Mr. Derek J. Maetzold is at least $101,443,129 as of 17 Dec 2024. He owns shares worth $1,686,764 as insider, has earned $94,656,365 from insider trading and has received compensation worth at least $5,100,000 in Castle Biosciences, Inc..
What is the salary of Derek J. Maetzold?
Mr. Derek J. Maetzold salary is $1,020,000 per year as Founder, Chief Executive Officer, Pres & Director in Castle Biosciences, Inc..
How old is Derek J. Maetzold?
Mr. Derek J. Maetzold is 63 years old, born in 1962.
What stocks does Derek J. Maetzold currently own?
As insider, Mr. Derek J. Maetzold owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Castle Biosciences, Inc. (CSTL) | Founder, Chief Executive Officer, Pres & Director | 84,762 | $19.9 | $1,686,764 |
What does Castle Biosciences, Inc. do?
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Derek J. Maetzold insider trading
Castle Biosciences, Inc.
Mr. Derek J. Maetzold has made 738 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 9,252 units of CSTL stock worth $262,137 on 17 Dec 2024.
The largest trade he's ever made was exercising 65,627 units of CSTL stock on 12 May 2020. As of 17 Dec 2024 he still owns at least 84,762 units of CSTL stock.
Castle Biosciences key executives
Castle Biosciences, Inc. executives and other stock owners filed with the SEC:
- Mr. Bernhard E. Spiess (65) Chief Bus. Officer
- Mr. Derek J. Maetzold (63) Founder, Chief Executive Officer, Pres & Director
- Mr. Frank Stokes (55) Chief Financial Officer